Kotak Funds India Mid Cap Fund

As of Jun 2026, Kotak Funds India Mid Cap Fund — an institution tracked through public shareholding filings — disclosed 16 holdings in Indian listed companies worth ₹6,800 crore. The same holdings-at-filing-value basis put it at ₹8,125 crore in Mar 2026 (−16.3%). Solomo carries these filings back to Sep 2017.

Largest disclosed positions in Jun 2026: Sansera Engineering Ltd (SANSERA — 4.81% of the company, ₹975 crore); Laurus Labs Ltd (LAURUSLABS — 1.01% of the company, ₹838 crore); Fortis Healthcare Ltd (FORTIS — 1.13% of the company, ₹833 crore); Max Financial Services Ltd (MFSL — 1.04% of the company, ₹575 crore); Ipca Laboratories Ltd (IPCALAB — 1.14% of the company, ₹516 crore). Those 5 account for 55% of the disclosed value.

Changes in the Jun 2026 filings: Stake reduced in Rolex Rings Ltd (−0.75 pp), Apollo Tyres Ltd (−0.21 pp), Sansera Engineering Ltd (−0.15 pp). No longer disclosed after the previous quarter: Max Healthcare Institute Ltd, J K Cements Ltd, Navin Fluorine International Ltd, Thermax Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.